Back

Counting Cases and Deaths by Age Tells Us About COVID-19 Infectious and Lethal Components

Michaelson, J. S.

2023-01-07 infectious diseases
10.1101/2023.01.05.23284239 medRxiv
Show abstract

Gauging COVID-19s lethality, and how vaccination can reduce that lethality, has been challenging. Here, a new method, Gompertzian Analysis, counting cases and deaths, by age, and displaying them on logarithmic graphs, is outlined, and its first findings presented: FIRST, COVID-19 Gompertzian Lethality (Deaths/Cases) exhibits an ~10,000-fold exponential increase in the chance of death with age, the Gompertzian Force of Mortality, captured by the Gompertz Mortality Equation. SECOND, COVID-19 Pasteurian Infectivity (Cases/Population) occurs at similar rates across ages. THIRD, the same Gompertzian Force of Mortality characterizes other diseases and all-cause mortality, possibly from loss of Mitotic Dilution of toxic compounds due to decline in mitosis. FOURTH, resistance to COVID-19 infectivity and lethality appear to be separate processes. FIFTH, Over the past several years, Gompertzian Lethality, has declined, but not Pasteurian Infectivity. SIXTH, with each variant, Gompertzian Lethality has declined, but not Pasteurian Infectivity. SEVENTH, the unvaccinated have seen a decline in Gompertzian Lethality, less than the vaccinated, ascribable to infection, at the cost of lives lost. EIGHTH, different vaccines have different reductions in Gompertzian Lethality and Pasteurian Infectivity. NINTH, vaccination has reduced Pasteurian Infectivity, but not enough to suppress the pandemic. TENTH, vaccination has reduced Gompertzian Lethality, with sequential vaccination pointing linearly towards zero death after 3 or 4 boosters, without signs of waning. CONCLUSION: Gompertzian Analysis provides new, practical, actionable, information for understanding, and minimizing, the lethal burden of COVID-19 and other diseases.

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

1
Demographic Research
11 papers in training set
Top 0.1%
12.6%
2
PLOS ONE
5266 papers in training set
Top 23%
7.4%
3
Annals of Internal Medicine
28 papers in training set
Top 0.1%
5.6%
4
Scientific Reports
3612 papers in training set
Top 15%
5.6%
5
Vaccines
198 papers in training set
Top 0.7%
4.4%
6
Frontiers in Public Health
148 papers in training set
Top 1%
4.4%
7
Journal of The Royal Society Interface
235 papers in training set
Top 1%
3.3%
8
Frontiers in Aging
11 papers in training set
Top 0.1%
3.3%
9
BMJ Open
601 papers in training set
Top 7%
2.8%
10
Biology Methods and Protocols
61 papers in training set
Top 0.4%
2.5%
50% of probability mass above
11
eClinicalMedicine
77 papers in training set
Top 0.6%
2.1%
12
Frontiers in Medicine
120 papers in training set
Top 2%
2.1%
13
PNAS Nexus
159 papers in training set
Top 0.7%
1.9%
14
JAMA Network Open
130 papers in training set
Top 2%
1.9%
15
Aging
75 papers in training set
Top 0.8%
1.8%
16
BMC Medicine
176 papers in training set
Top 2%
1.8%
17
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 34%
1.1%
18
International Journal of Infectious Diseases
129 papers in training set
Top 2%
1.1%
19
iScience
1154 papers in training set
Top 24%
1.1%
20
eLife
5828 papers in training set
Top 59%
1.1%
21
European Journal of Epidemiology
43 papers in training set
Top 0.6%
1.1%
22
American Journal of Epidemiology
67 papers in training set
Top 1%
1.1%
23
International Journal of Environmental Research and Public Health
128 papers in training set
Top 5%
1.0%
24
PLOS Global Public Health
344 papers in training set
Top 7%
1.0%
25
BMC Public Health
158 papers in training set
Top 5%
1.0%
26
Heliyon
152 papers in training set
Top 6%
1.0%
27
Clinical Infectious Diseases
235 papers in training set
Top 3%
0.9%
28
Royal Society Open Science
214 papers in training set
Top 6%
0.9%
29
Journal of Theoretical Biology
162 papers in training set
Top 2%
0.9%
30
JMIR Public Health and Surveillance
45 papers in training set
Top 2%
0.9%